
Smarter Trial Execution. Faster Breakthroughs.
CLINIQ helps high-risk clinical trial teams handle workflow exceptions using SOP- and protocol-based guidance.
Cited guidance when supported. Required escalation when it is not.
Small Exceptions Can Threaten Critical Trial Data
Missed toxicity checks
Late or missing CRS / ICANS safety checks in time-critical windows.
Out-of-window specimens
Time-sensitive biomarker collections that fall outside protocol.
Chain-of-custody gaps
Temperature excursions, labelling errors, and handoff failures.
Unclear deviation / CAPA escalation
Ambiguity on what to escalate, when, and to whom.
Trial teams need support at the moment risk occurs—not only documentation after the event.
Evidence or Escalation. Nothing in Between.
Every CLINIQ response is grounded in approved source text—or stops and routes to the right authority.
Workflow exception occurs
An event falls outside expected protocol.
CLINIQ retrieves approved SOP / protocol
Pulls language from governed source documents.
Checks whether the source supports action
Citation-gated decision logic.
Returns cited, stepwise guidance
- Source quote and reference
- Sequenced next actions
- Confidence visible to the user
Stops and escalates
- Routes to PI, QA, pharmacy, monitor
- Captures rationale for escalation
- No fabricated guidance, ever
Creates an audit-ready record
Decision, citation, escalation path, and timestamp—captured automatically.
No clinical judgment. No unsupported improvisation. No silent failure.
A research-stage prototype, available on request.


CLINIQ is a secured research-stage prototype demonstrating citation-gated guidance and escalation behavior using sample SOPs.
Built From the Operational Problem

Mana Kashuk
MSc, MBA, PhD Candidate
Founder
Mana's work spans translational science, clinical research operations, governed AI workflows, and commercialization. CLINIQ was developed to address a specific gap in high-risk trial execution: helping teams find supported next steps—or escalate when the approved source is unclear.
From Proof of Concept to Validated Product
Selected for GCC REACH Stage 2 Strategic Advisory Team-assisted Product Commercialization Plan development.
- Milestone 01GCC REACH Stage 2
- Milestone 02Customer discovery
- Milestone 03Workflow & swimlane mapping
- Milestone 04Retrospective / simulated validation
- Milestone 05Usability testing
- Milestone 06Security & integration planning
- Milestone 07SBIR / STTR readiness
What CLINIQ Must Prove
Before any live workflow pilot, CLINIQ must demonstrate safe, traceable, and operationally useful behavior through controlled simulation and expert review.
Teams operating where precision matters most.
Designed around the needs of teams operating in high-risk clinical trial workflows.
Let's Improve How High-Risk Trials Handle the Unexpected.
For advisory discussions, customer discovery interviews, prototype review, or future pilot exploration.
hello@cliniqtrial.com